11-Jun-2026
Privia Health Group (PRVA) Gets a Buy from Truist Financial
TipRanks (Mon, 8-Jun 7:35 AM ET)
Privia Health Enters New Jersey
Globe Newswire (Wed, 27-May 9:00 AM ET)
Privia Health Reports First Quarter 2026 Financial Results
Globe Newswire (Thu, 7-May 6:00 AM ET)
Privia Health to Report First Quarter 2026 Results on Thursday, May 7
Globe Newswire (Wed, 8-Apr 9:00 AM ET)
Privia Health Earns 2026 HFMA MAP Award for Revenue Cycle Excellence
Globe Newswire (Tue, 24-Mar 9:00 AM ET)
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
Privia Health Group trades on the NASDAQ stock market under the symbol PRVA.
As of June 11, 2026, PRVA stock price climbed to $23.36 with 867,636 million shares trading.
PRVA has a beta of 0.89, meaning it tends to be less sensitive to market movements. PRVA has a correlation of 0.13 to the broad based SPY ETF.
PRVA has a market cap of $2.94 billion. This is considered a Mid Cap stock.
Last quarter Privia Health Group reported $604 million in Revenue and $.19 earnings per share. This beat revenue expectation by $42 million and missed earnings estimates by -$.03.
In the last 3 years, PRVA traded as high as $29.42 and as low as $15.92.
The top ETF exchange traded funds that PRVA belongs to (by Net Assets): IJR, VTI, VB, IWM, VBK.
PRVA has underperformed the market in the last year with a return of +1.5%, while the SPY ETF gained +23.9%. In the last 3 month period, PRVA fell short of the market, returning +5.8%, while SPY returned +9.3%. However, in the most recent 2 weeks PRVA has outperformed the stock market by returning +8.2%, while SPY returned -2.2%.
PRVA support price is $22.43 and resistance is $23.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRVA shares will trade within this expected range on the day.